- Home
- CAC vs PHAR Comparison
CAC vs PHAR Comparison
Compare CAC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- PHAR
- Stock Information
- Founded
- CAC 1875
- PHAR 1988
- Country
- CAC United States
- PHAR Netherlands
- Employees
- CAC N/A
- PHAR N/A
- Industry
- CAC Major Banks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- PHAR Health Care
- Exchange
- CAC Nasdaq
- PHAR Nasdaq
- Market Cap
- CAC N/A
- PHAR 618.3M
- IPO Year
- CAC 1997
- PHAR N/A
- Fundamental
- Price
- CAC $45.32
- PHAR $8.42
- Analyst Decision
- CAC Hold
- PHAR Strong Buy
- Analyst Count
- CAC 3
- PHAR 3
- Target Price
- CAC $48.33
- PHAR $27.00
- AVG Volume (30 Days)
- CAC 87.0K
- PHAR 5.6K
- Earning Date
- CAC 01-28-2025
- PHAR 03-13-2025
- Dividend Yield
- CAC 3.74%
- PHAR N/A
- EPS Growth
- CAC 21.89
- PHAR N/A
- EPS
- CAC 3.62
- PHAR N/A
- Revenue
- CAC $177,396,000.00
- PHAR $285,745,000.00
- Revenue This Year
- CAC N/A
- PHAR $20.08
- Revenue Next Year
- CAC $10.12
- PHAR $9.22
- P/E Ratio
- CAC $12.27
- PHAR N/A
- Revenue Growth
- CAC 10.05
- PHAR 30.64
- 52 Week Low
- CAC $28.62
- PHAR $6.65
- 52 Week High
- CAC $50.07
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- CAC 59.96
- PHAR 40.05
- Support Level
- CAC $43.76
- PHAR $7.95
- Resistance Level
- CAC $46.49
- PHAR $9.35
- Average True Range (ATR)
- CAC 1.18
- PHAR 0.52
- MACD
- CAC 0.24
- PHAR -0.16
- Stochastic Oscillator
- CAC 81.18
- PHAR 22.76
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.